首页> 外文期刊>WIPO Magazine >THE FALL AND RISE OF PHARMA BRAND NAMES
【24h】

THE FALL AND RISE OF PHARMA BRAND NAMES

机译:药房品牌名称的下降和上升

获取原文
获取原文并翻译 | 示例
           

摘要

Stand out - but innocuously! This would seem to be the goal, judging by pharma brand names launched in the recent past. A paradox, for sure. But it makes sense if you consider the following: don't stand out and you get lost in the crowd; stand out too much and your flashiness may undermine your credibility. Pharma marketers are not only concerned about over-promising and underdelivering to physician and patient audiences, they are also fearful of rejections by regulatory authorities such as the US Food and Drug Administration (FDA) and the European Medicines Agency (EMEA). Add to this the ongoing media and government blitz against the pharma industry, and it is no wonder a new conservatism in pharma branding is prevailing. Thus, despite all the talk of differentiation, it seems the ultimate driver in brand name develop?ment is credibility.
机译:脱颖而出-但要毫不含糊!从最近推出的制药品牌来看,这似乎是目标。无疑是一个悖论。但是,如果考虑以下因素,这是有道理的:不要脱颖而出,迷失在人群中;太突出了,浮华可能会损害您的信誉。药品营销人员不仅担心医师和患者听众的承诺过高和供不应求,还担心美国食品药品管理局(FDA)和欧洲药品管理局(EMEA)等监管机构拒绝这样做。除此之外,媒体和政府对制药业的热烈抗议也就不足为奇了,这也就不足为奇了。因此,尽管谈论差异化,但品牌发展的最终动力似乎是信誉。

著录项

  • 来源
    《WIPO Magazine》 |2008年第3期|共2页
  • 作者

  • 作者单位
  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 专利;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号